openPR Logo
Press release

Cell Line Development Market Prominent Players – GE Healthcare, Thermo Fisher Scientific, Lonza Group, Sigma-Aldrich Corporation, Wuxi AppTec, Sartorius Stedim Biotech, Corning, Selexis, Vista Biologics, EuBiologics, Paragon Bioservices, Cobra Biologics

11-12-2018 02:33 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Cell Line Development Market Share - Industry Size Report 2018-2024

Cell Line Development Market Share - Industry Size Report 2018-2024

Regarded as a one of the rapidly progressing fraternities of the life science domain, cell line development market has established itself as a major business sphere of recent times. With tissue and cell-based assays rapidly swapping animal studies, researchers are increasingly becoming dependent on cell study to demonstrate greater biological relevance. As per the data put forth by the World Health Organization, neurological disorders and their consequences are anticipated to affect more than one billion people worldwide.

This data is evident from the rising aging population and lack of effective treatments – a factor also underpinning the necessity to develop new assays to advance research and develop know-how with regards to the mechanism of these diseases. Given the fact that both industrial and research concerns are demanding advanced & better cells for developing novel vaccines, biosimilars, drug, and therapeutic proteins it comes as no surprise that the global cell line development market has bright growth prospects. A conjecture substantiating the same is of a report compiled by Global Market Insights, Inc., that claims the global cell line development market to become a massive 7.5-billion-dollar industry by 2024, a substantial up from USD 3.3 billion in 2017.

Get a Sample Copy of this Report:@https://www.gminsights.com/request-sample/detail/429

When it comes to the vast utilization of the cell line development technology, Berkeley Lights Inc., is one protuberant industry magnates that has developed a platform to address the unmet research needs in Cellular Immuno-Oncology, BioPharma, and Autologous T-cell Therapies. Introduction of Beacon platform by this company has undeniably changed the overall competitive dynamics of cell line development industry. In fact, it has been observed that several other market players are leveraging Berkeley Lights’ state-of-the-art technology to further dive deeper into cell line research.

Impact of Berkeley Lights, Inc’s Beacon platform on the competitive landscape of cell line development market

According to reliable reports, Berkeley Lights, Inc. (BLI) launched its first commercial platform – Beacon™ OptoFluidic Platform in December 2016. This platform is ideally suited for direct B-cell antibody discovery and cell line development workflows. Experts deem that the flexibility of this platform has allowed researchers to automate biological processes and develop new applications to align with specific requirements. In short, the Beacon platform has enabled efficient monitoring, visualization, and tracking of cell to cell interaction and single cell manipulation across thousands of cells into a nanofluidic chip.

As a result of this breakthrough technology, customers and other cell line development industry players could accelerate the delivery of actionable results and reduce hands-on time. Taking into account the Beacon platform’s ability to interact with cells in novel ways, BLI’s prominence in cell line development industry has indeed strengthened.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/429

Leading biotechnology company Shire adopts BLI’s Beacon OptoFluidic platform

Recently in January 2018, BLI announced that Shire is implementing the Beacon Platform to accelerate their CLD process. Reports reveal that the company’s decision was based on an experiment and study that equated their existing cell line development workflow to the workflow results obtained using Beacon.

Daiichi Sankyo to work with BLI’s Beacon™ OptoFluidic

BLI in October 2017 announced that it will be working with the global pharmaceutical industry player Daiichi Sankyo to focus on creating CLD workflow efficiencies and fast tracking the drug development process. According to sources, the program includes evaluating and predicting the stability of clones, establishing monoclonality, and screening a pool of recently transfected CHO cells.

Pfizer to invests in mAb discovery with BLI’s Beacon tech
In a recent news snippet released in January 2018, it has been reported that Pfizer is leveraging BLI’s Beacon platform to advance its gene editing programs and monoclonal antibody discovery.

Other large pharma companies implementing Beacon technology
Teva Pharmaceuticals Australia, recently announced that it will be installing Beacon for its CLD and antibody discovery programs. Bayer Inc., is another in the line that has announced a strategic project with BLI to innovate and accelerate research. The pharmaceutical giant Novartis is also not far behind in implementing the Beacon platform. In fact, reports reveal it to be an earlier adopter of this technology and to consequently have secured its position in the dynamic cell line development market.

Overall a common thread that runs through all the aforementioned trends is BLI’s rising preeminence in the global cell line development industry. The flexibility of the Beacon platform has not only allowed BLI to strengthen its roots in this industry by continuously aligning with its partner’s requirements but has also significantly aided other emerging cell line development market players. What is noteworthy about these prospective trends is that they are deemed to be extremely important for other cell line development industry players in designing their growth tactics to sustain in the competitive terrain. For the record, other prominent companies partaking in cell line development industry share include GE Healthcare, Thermo Fisher Scientific, Lonza Group, Sigma-Aldrich, Sartorius AG, Progenitor Cell Therapy, LLC, and Samsung Biologics Co., Ltd.

Report Content

Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data Sources
1.4.1. Secondary
1.4.1.1. Paid Sources
1.4.1.2. Unpaid Sources
1.4.2. Primary

Chapter 2. Executive Summary
2.1. Cell line development industry 360° synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Source trends
2.1.4. Cell line type trends
2.1.5. Application trends
2.1.6. Regional trends

Chapter 3. Cell Line Development Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rise in production of vaccines globally
3.3.1.2. Increasing number of cancer incidences especially in developing countries such as India and China
3.3.1.3. Extended applications of biotechnology sector
3.3.1.4. Patent expiration of blockbuster biologics leading to innovations in the field
3.3.1.5. Escalating demand for monoclonal antibodies in U.S. and Europe
3.3.1.6. Technological advancements in cell line development
3.3.2. Industry pitfalls & challenges
3.3.2.1. Ambiguous regulatory landscape
3.3.2.2. Growing concerns related to stem cell research
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By source
3.4.3. By cell line type
3.4.4. By application
3.5. Porter’s analysis
3.6. Regulatory landscape
3.6.1. U.S.
3.6.2. Europe
3.6.3. China
3.7. Company landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cell Line Development Market Prominent Players – GE Healthcare, Thermo Fisher Scientific, Lonza Group, Sigma-Aldrich Corporation, Wuxi AppTec, Sartorius Stedim Biotech, Corning, Selexis, Vista Biologics, EuBiologics, Paragon Bioservices, Cobra Biologics here

News-ID: 1362431 • Views: 939

More Releases from Global Market Insights, Inc.

Ethylene Propylene Diene Monomer Market will generate admirable revenue by 2024
Europe ethylene propylene diene monomer (EPDM) market is predicted to record significant gains over the coming timeframe. The increasing demand for EPDM across the construction sector will stimulate the UK EPDM industry trends, which is predicted to exhibit a CAGR of more than 4% over the coming years of 2016 to 2024. North America EPDM industry worth USD 600 million in 2015, will register a considerable growth over the coming years.
Healthcare PMMA Market Future Challenges and Industry Growth Outlook 2024
U.S. Healthcare PMMA Market led the industry demand for North America. It was evaluated at more than $48.1 million for 2015. Large aging population in U.S. along with strict FDA (Food and Drug Administration) rules to reduce use of harmful plastics in medical sector is predicted to favorably influence industry expansion. Europe Healthcare PMMA Market, dominated by Italy, UK, France, Spain and Germany, is anticipated to record CAGR of about 5%
Natural Gas Liquids Market Share to grow at 7% CAGR by 2025
Japan NGL market is set to exceed the consumption of 0.2 mbl/day by 2025. Growing demand for high value-added manufactured petrochemicals coupled with accelerating investments toward chemical industry will propel the industry growth. Furthermore, rapidly expanding various industrial bases including refineries, chemicals and manufacturing industries along with ongoing funding toward automotive sector will encourage the product penetration. Get sample copy of this research report @https://www.gminsights.com/request-sample/detail/3270 Reduced emissions from industries, lower electricity costs,
Oil Pipeline Infrastructure Market Share By Industry Growth, Trend and Forecast …
Global Market Insights added a new report on global Oil Pipeline Infrastructure Market to its research database. The report focuses on global major leading players with information such as company profiles, growth, product segment, technology segment, end user segment and region. The U.S. oil pipeline infrastructure market size will surpass the cumulative installation of 450,000 km in 2018. Upgradation of drilling technologies coupled with robust investment in infrastructure development will stimulate

All 5 Releases


More Releases for Beacon

Global Beacon Lights Industry Market Analysis & Forecast
In the Global Beacon Lights Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of
Global Smart Beacon Sales Market Report
Get sample copy of the report: https://www.marketdensity.com/contact?ref=Sample&reportid=30574 Table of Contents: Table of Contents Global Smart Beacon Sales Market Report 2018 1 Smart Beacon Market Overview 1.1 Product Overview and Scope of Smart Beacon 1.2 Classification of Smart Beacon by Product Category 1.2.1 Global Smart Beacon Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 Global Smart
Global Beacon Lights Market Professional Survey Report
This report studies Beacon Lights in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Alphatronics Arcus Light AUER BANNER ENGINEERING BEKA CIRCONTROL CITEL Contrel elettronica D.G Controls
Global Smart Beacon Market Research Report
This report studies the global Smart Beacon market status and forecast, categorizes the global Smart Beacon market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other regions. The global Smart Beacon market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the
Beacon Lights Market
The global beacon lights market has earned prominence due to increasing deployment of defense and medical vehicles over the past few years. The number of military vehicles and emergency vehicles such as fire engines and ambulances have increased considerably in recent years. Factors such as increase in disposable income that have led to the demand for improved healthcare, which in turn, has boosted the demand for emergency vehicles and hospitals
Bluetooth Beacon And Ibeacon Market
Understanding several aspects of the global Bluetooth beacon and iBeacon market, Persistence Market Research has presented a well-structured analysis on several trends, challenges, opportunities, restraints and drivers impacting the growth of the global market in its recent publication “Bluetooth Beacon and iBeacon Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. These aspects are studied across key regions of North America, Europe, Asia Pacific, Latin America and Middle East and